Upfront thoracic radiotherapy to primary lession improve outcomes in patients with stage IV non-small cell lung cancer harboring EGFR mutations.

dc.contributor.authorYildrim, Berna Akkus
dc.contributor.authorTopkan, Erkan
dc.date.accessioned2022-08-02T11:34:52Z
dc.date.available2022-08-02T11:34:52Z
dc.date.issued2021
dc.identifier.endpagee21167en_US
dc.identifier.issn0732-183Xen_US
dc.identifier.issue15en_US
dc.identifier.startpagee21167en_US
dc.identifier.urihttp://hdl.handle.net/11727/7193
dc.identifier.volume39en_US
dc.identifier.wos000708120305141en_US
dc.language.isoengen_US
dc.relation.isversionof10.1200/JCO.2021.39.15_suppl.e21167en_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleUpfront thoracic radiotherapy to primary lession improve outcomes in patients with stage IV non-small cell lung cancer harboring EGFR mutations.en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: